CD4 and HIV infectious disease: CREST-L overcomes previous limitations of modeling latency in resting T cells by achieving the high levels of HIV infection necessary to examine latency reversal phenotypes without a need for cell activation in resting CD4+ T cells, an important but previously less tractable cell population.